A 34-year-old patient came in last summer carrying a diagnosis she had received at 19, then called PCOS and now called PMOS. Her treatment for the entire intervening fifteen years had been birth control pills and metformin. The pills had been switched four times for various side effect reasons. Nobody had ever run a complete hormonal panel on her. She came in because she wanted to come off the pill, she wanted to address the 35 pounds she had gained over the last decade, and she wanted to know whether she could conceive in the next few years if she chose to.
Her labs were a textbook PMOS picture that nobody had bothered to characterize. Fasting insulin of 22 mIU/L. HOMA-IR of 4.9. LH-to-FSH ratio of 2.8. Total testosterone of 78 ng/dL with a free testosterone in the upper range. SHBG of 18 nmol/L. Anti-mullerian hormone elevated. Vitamin D at 16. Reverse T3 elevated with a borderline-low free T3. Her estradiol was suppressed because she had been on hormonal birth control for fifteen years, which meant her endogenous reproductive axis had not had a chance to function in over a decade.
The PMOS diagnosis was correct. The treatment had been targeting symptoms — the menstrual irregularity and the androgen-driven complaints — without ever addressing what was actually driving them. That is the conversation I want to have here, because PMOS is one of the most poorly managed conditions in conventional women's health, and the consequences of poor management land hardest in the years between 35 and 50.
What PMOS actually is, mechanically
Polyendocrine Metabolic Ovarian Syndrome (PMOS), formerly Polycystic Ovary Syndrome (PCOS), involves hormonal, reproductive, and metabolic health. The updated name better reflects that broader picture. The former name could misleadingly suggest that ovarian cysts define the condition; the Endocrine Society explains that PMOS does not involve an increase in abnormal ovarian cysts. Individual symptoms and care needs vary.
The mechanism that drives most cases looks like this: insulin resistance at the cellular level forces compensatory hyperinsulinemia. Elevated insulin acts on the ovarian theca cells to stimulate androgen production. Elevated insulin also suppresses hepatic SHBG production, which means more of the testosterone that is being produced exists in its free, biologically active form. The hypothalamic-pituitary axis responds to the altered androgen and estrogen environment with a higher LH-to-FSH ratio, which preferentially drives further androgen production rather than normal follicular maturation. Follicles start to develop but stall before ovulation, sometimes producing the small-follicle appearance seen on ultrasound. Ovulation becomes irregular or absent. Progesterone production from the corpus luteum drops because there is no corpus luteum without ovulation. Unopposed estrogen builds the endometrium without the cyclical shedding that progesterone normally triggers, which is why the menstrual cycles are unpredictable and often heavy when they do come.
Read that mechanism and you can see why birth control pills do not actually treat PMOS. The pill suppresses the entire reproductive axis from the top down. It produces a regular withdrawal bleed and addresses the androgenic skin and hair complaints by raising SHBG and reducing free testosterone. It does nothing for the underlying insulin resistance. In fact, some formulations worsen it. The patient's labs look better while she is on the pill because the pill is masking the system rather than fixing it. The minute she comes off, the underlying picture is still there, frequently worse than when she started. Even when the underlying driver is treated, hair that has already grown in still needs physical removal, and I compare laser or electrolysis for PMOS hair in a separate piece.
Why metformin alone is also incomplete
Metformin addresses the insulin resistance piece directly, and for a lot of patients it does meaningful work. It improves insulin sensitivity at the muscle and the liver, lowers fasting insulin, and can restore ovulation in some patients with PMOS-driven anovulation. I prescribe it. I think it is a useful tool. But metformin alone, in my experience, addresses maybe forty to sixty percent of the picture in most PMOS patients. The pieces it does not address — sex hormone imbalance, thyroid dysfunction that frequently coexists, vitamin D deficiency that is common in this population, sleep architecture that is wrecked by years of metabolic dysregulation, and the lifestyle interventions that move the needle on insulin sensitivity faster than any medication — get left on the table.
The patients I see who have been on metformin for years without other intervention have typically improved on some markers and plateaued on others. The symptoms that frustrated them initially are partly better and partly the same. The weight has not budged. The fatigue persists. The mood and cognitive symptoms persist. The picture is incomplete because the treatment was incomplete. The androgenic complaints persist right alongside them, and in younger women PMOS is the most common reason coarse facial hair shows up well before midlife. Acne is often part of the same picture, and hormonal breakouts along the jaw and chin are one of the androgen signs I ask about.
What I look for in the workup
When a PMOS patient sits down with me, I am working through a specific list. The history covers age at diagnosis, the menstrual history before any hormonal interventions started, prior treatments and their outcomes, current symptom burden, family history of PMOS and metabolic disease, fertility goals if any, and lifestyle baseline — sleep, exercise, dietary pattern, alcohol use, stress sources. The same hyperinsulinemia that drives the ovarian picture can also leave visible marks, and the skin signs of insulin resistance, such as darkened, velvety patches at the neck or underarms, are worth mentioning at that visit.
Assessment is individualized. We review your history, symptoms, medicines, prior records, and goals before recommending any testing or follow-up. No single panel is appropriate for every patient. The initial consultation is a chance to discuss what additional information, if any, would help guide your care.
Discuss PMOS (formerly PCOS) care in person
Explore evaluation, care goals, and ongoing management at the Columbus or Warner Robins clinic.
Your clinician also considers other possible explanations for your symptoms and whether specialist coordination is appropriate. Bring previous results so they can be interpreted in context rather than assuming that a single result establishes the diagnosis. For educational background, see high testosterone results in women.
How treatment proceeds when the workup confirms it
Treatment is mechanism-first and layered. The non-negotiable foundation is addressing insulin resistance, because every other piece of the picture downstream of it. That means metformin or a GLP-1 receptor agonist when warranted, structured nutritional changes that reduce insulin secretory demand (lower glycemic load, adequate protein, eating windows that allow insulin to drop between meals), and resistance training because skeletal muscle is the largest insulin-sensitive tissue in the body and building it directly improves insulin signaling. Vitamin D repletion to the optimal range (50 to 80 ng/mL, not just above the deficiency cutoff at 30) measurably improves insulin sensitivity and androgen markers in deficient PMOS patients.
Hormone optimization for PMOS is more nuanced than the standard menopause protocol because the underlying picture is hyperandrogenic and often estrogen-dominant in a functional sense. Bioidentical progesterone, dosed cyclically or continuously depending on the picture, addresses the unopposed estrogen problem and protects the endometrium. It also has direct GABAergic effects that help with the sleep and anxiety symptoms that are common in this population. For patients in their 40s where ovarian function is starting to decline against an already disrupted background, low-dose estradiol may be added — but the candidacy conversation here is more careful than in a non-PMOS perimenopausal patient.
Biote pellet therapy is appropriate for some PMOS patients in mid-life — particularly those with low free testosterone (which does happen in PMOS, even with elevated ovarian production, when SHBG is high or when ovarian function has declined) and a clear fatigue and libido picture. Not every PMOS patient is a pellet candidate. Selection matters.
For patients with significant weight to address as part of the picture, the medical weight loss program runs in parallel with the hormonal work — and when GLP-1 therapy is appropriate, it addresses both the weight and the underlying insulin resistance simultaneously. The combination of GLP-1 plus appropriate hormonal management is the most effective intervention I have seen for the PMOS phenotype that has progressed into mid-life with significant metabolic and weight burden.
Thyroid correction, when the panel shows it is needed, is not optional. PMOS patients with untreated subclinical thyroid dysfunction do not respond to the rest of the protocol the way they should.
What I look for in candidacy and what I will not treat
Good candidates for the layered approach I have described are patients with confirmed PMOS on a complete workup, realistic expectations about timeline (this is a 6-to-12-month optimization arc, not a 6-week fix), and willingness to engage with the lifestyle interventions that the medications support but do not replace. I will not start a PMOS protocol on a patient who has not had a complete workup, and I will not continue a protocol that the data does not support. If the labs at three months show that the intervention is not producing the expected response, we adjust based on the data — sometimes that means a different intervention, sometimes a referral to a reproductive endocrinologist, sometimes acknowledging that a particular goal is not achievable with the tools I have.
For patients with active fertility goals, I am explicit that PMOS-driven infertility is best managed in coordination with a reproductive endocrinologist. I can do the foundational metabolic and hormonal work that improves the substrate for fertility treatment. I am not the right provider to run an IVF cycle.
The next step if this is your picture
If you are carrying a PMOS diagnosis that has been managed with the pill or metformin alone for years, and what I have described changes how you are thinking about your situation, the right next step is a real workup. Book a consultation at the Columbus location or the Warner Robins location and bring whatever prior labs you have. The hormone health assessment is a useful five minutes of self-assessment to do before booking — it will help you arrive with the picture organized.
The patient I opened with came off the pill over three months under controlled monitoring, started a GLP-1 with a conservative titration, addressed her vitamin D and reverse T3, and added cyclical progesterone once her endogenous cycles began returning. Eight months in, her fasting insulin had dropped to 9, she had lost 19 pounds, her cycles had returned at a 32-day rhythm, and her free testosterone had normalized. She is currently weighing whether to start trying to conceive in the next year — a conversation that was effectively closed to her on the protocol she had been on for fifteen years. The intervention that worked was the one that addressed the underlying mechanism rather than masking the surface picture.
Medical disclaimer: This article is for educational purposes only and does not constitute medical advice. Individual clinical decisions should be made in consultation with a qualified healthcare provider following appropriate evaluation. References to specific treatments, dosing, or protocols are informational.
Travis spent 17+ years in high-acuity clinical medicine — emergency, cardiac ICU, and cath lab — before founding Revitalize. He is a Certified Platinum Biote hormone therapy provider, the published author of You're Not Broken — You're Unbalanced, and the founder of the Rebuild Metabolic Health Institute. His clinical writing reflects the same precision he brought to critical care: specific, honest, and built around what actually works.
Ready to talk it through with a clinician?
Book online or call either Georgia location. Every visit starts with a consultation.